Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marie-Laure Colaiacovo"'
Autor:
Mathias Castonguay, Nawar Dakhallah, Justin Desroches, Marie-Laure Colaiacovo, Camille Jimenez-Cortes, Anne-Marie Claveau, Samuel Bérubé, Amer Yassine Hafsaoui, Amalia Souza, Pauline Tibout, Christophe Ah-Yan, Anne-Marie Vincent, Veronique Naessens, Josée Brossard, Sharon Abish, Raoul Santiago, Denis Soulières, Vincent Laroche, Yves Pastore, Thai Hoa Tran, Stéphanie Forté
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 24; Pages: 7361
Background: Patients with sickle cell disease (SCD) are considered at higher risk of severe COVID-19 infection. However, morbidity and mortality rates are variable among countries. To date, there are no published reports that document outcomes of SCD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95b318efd8d4ac299b54edfb8c2d695
https://pubmed.ncbi.nlm.nih.gov/36555978
https://pubmed.ncbi.nlm.nih.gov/36555978
Autor:
Camille Jimenez-Cortes, Marie-Laure Colaiacovo, Amalia Souza, Amer Yassine Hafsaoui, Vincent Laroche, Anne-Marie Claveau, Pauline Tibout, Justin Desroches, Raoul Santiago, Veronique Naessens, Stéphanie Forté, Denis Soulières, Thai Hoa Tran, Nawar Dakhallah, Anne-Marie Vincent, Mathias Castonguay, Yves D. Pastore, Sharon Abish, Josee Brossard
Publikováno v:
Blood
Introduction Approximately 1500 people live with sickle cell disease (SCD) in the province of Quebec, Canada. Public health has recognized these patients as immunocompromised. SCD patients may be at higher risk of developing severe COVID-19 infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f8054ad1815ad215b367eba212bf1c
https://doi.org/10.1182/blood-2021-151361
https://doi.org/10.1182/blood-2021-151361
Autor:
Amalia Souza, Christophe Ah-Yan, Thai Hoa Tran, Pascal Bernier, Nawar Dakhallah, Marie-Laure Colaiacovo, Henrique Bittencourt, Jean-Marie Leclerc, Caroline Laverdière, Camille Jimenez-Cortes
Publikováno v:
Pediatric Blood & Cancer
To the Editor,We read the letter entitled “Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19 ” by Marcia et al . with great interest and we hereby suggest to start chemotherapy within the same timeline as for non-COVID-19 acu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8190741bfbe2f1c27ee63f3abb35942c
http://hdl.handle.net/2318/1757320
http://hdl.handle.net/2318/1757320
